Background and objective: Long-term pulmonary function which might include compensatory response (CR) significantly influences quality of life of long-term survivor after major lung resection. We investigated longterm pulmonary function after major lung resection. Results: FEV 1apo /FEV 1ppo showed strong correlation with FVC apo /FVC ppo (r = 0.628; P < 0.001). We defined greater CR as both FEV 1apo /FEV 1ppo and FVC apo /FVC ppo were >120%. Greater CR was significantly associated with decreased smoking index (P < 0.001) and greater resected subsegments (P = 0.037). The never-smoker group revealed significantly greater CR compared with the smoker group in both FEV 1apo /FEV 1ppo (119.9 AE 12.5% vs 107.5 AE 14.2%; P = 0.030) and FVC apo /FVC ppo (117.9 AE 9.98% vs 107.2 AE 13.1%; P = 0.046) in case-matched comparison. The expression of pro-SPC, TTF-1 and VEGFR2 in the normal lung parenchyma of greater CR group was significantly higher than those of lesser CR group (P < 0.001 for each). In addition, pro-SPC, TTF-1 and VEGFR2 expressions showed a significant correlation to the degree of CR especially in the smoker group (r = 0.631, 0.705 and 0.732, respectively; P < 0.001 for each). Conclusion: Our data suggest that smokers may develop lesser long-term CR after major lung resection.
INTRODUCTION
Major lung resections including lobectomy, bilobectomy and pneumonectomy are widely performed as oncologically optimal treatment choices for patients with non-small cell lung cancer (NSCLC) if they have sufficient cardiopulmonary reserve. 1, 2 Major lung resection leads to impairment of pulmonary function, 
SUMMARY AT A GLANCE
Long-term pulmonary function after lobectomy might include compensatory response (CR). In our study, the non-smoker group shows better long-term pulmonary function in case-matched comparison. Higher expression of pro-surfactant protein C (pro-SPC), thyroid transcription factor-1 (TTF-1) and vascular endothelial growth factor receptor 2 (VEGFR2) may contribute to CR. This is the first report showing predictors of long-term pulmonary function. thereby resulting in a higher risk for pulmonary complication and decreased quality of life (QOL). Longterm QOL has become more important as the prognosis of subjects with resected NSCLC has improved. 3 Impaired pulmonary function persists for at least 3 months after lung resection followed by gradual restoration including possible compensatory response (CR), which is considered as a time-dependent improvement of pulmonary function. 4 Most of the previous literature investigates short-term pulmonary function test (PFT) within 6 months after lung resection. 5, 6 However, long-term pulmonary function is not well understood, although it could significantly affect QOL and risk of pulmonary complications. Particularly, predictors of long-term PFT have not been reported to date. Possible difficulties for analysis of long-term PFT might include time-dependent changes. 7 Spirometrybased PFT is the only widely used gold standard method to evaluate pulmonary function in clinical practice, although recent reports have attempted to evaluate regional distribution of pulmonary function using perfusion scintigraphy or quantitative analysis on computed tomography (CT). 8, 9 Thus, we focused on the predictors of long-term CR based on PFT parameters because it is useful in predicting the long-term pulmonary function and QOL in daily practice.
Recent studies suggest that long-term pulmonary function after major lung resection might include CR and is often greater than that preoperatively predicted. 8, 9 Also, several studies demonstrated a significant contribution of some molecules such as vascular endothelial growth factor receptor 2 (VEGFR2), 10 thyroid transcription factor-1 (TTF-1) 11 and pro-surfactant protein C (pro-SPC) 11 in compensatory lung growth in rodents. However, it still remains controversial whether CR resembles compensatory lung growth in rodents. 11, 12 If CR after lung resection in adult human includes lung regeneration mechanisms similar to those involved in compensatory lung growth, these markers may be informative to identify similarities between these two phenomena. With this in mind, we focused on predictors of CR that may also provide useful information to consider indication for major lung resection. The objectives of this study were: (i) to examine the long-term pulmonary function and CR after major lung resection and (ii) to investigate predictors of CR and possible relationships with the expression of pro-SPC, TTF-1 and VEGFR2 that were reported to have significant impact on compensatory lung growth.
METHODS

Patients and surgical procedures
The subjects of our study included 142 consecutive patients who underwent lobectomy or greater resection for NSCLC from May 2013 to June 2014 at Teikyo University Hospital. This prospective observational study was approved by the Institutional Review Board (TU-13-025) and informed consent was obtained from all patients. One patient who underwent preoperative chemotherapy and two patients who developed pneumonia preoperatively, and another two were excluded due to the insufficient follow-up. All clinicopathological data were collected from medical records. All patients preoperatively underwent a physical examination, blood chemistry analysis, bronchoscopy, chest radiography, chest CT, brain MRI, integrated positron emission tomography and CT scan in accordance with the study protocol. ECG and spirometry were also performed for screening of cardiopulmonary diseases within 2 weeks prior to surgery. Operability was decided based on published guidelines. 13 All patients underwent lobectomy or bilobectomy and systematic nodal dissection via a small thoracotomy (7-10 cm) without rib excision.
Pulmonary function testing
PFTs including forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV 1 ) were performed at least twice and the best value was selected for analysis. The follow-up PFT was executed during 10-14 months after the operation based on the study protocol. Predicted post-operative FEV 1 (FEV 1ppo ) or predicted postoperative FVC (FVC ppo ) were calculated by the method as previously described 
Immunohistochemistry
For immunohistochemistry, one normal lung section which was separated from the tumour by >1 cm was selected per patient. Immunohistochemistry using the following antibodies was performed: antipro-SPC rabbit polyclonal antibody (clone ab40879; Abcam, Cambridge, UK), anti-TTF-1 mouse monoclonal antibody (clone 8G7G3/1; DAKO, Carpinteria, CA) and anti-VEGFR 2 rabbit monoclonal antibody (clone 55B11; Cell Signaling Technology, Danvers, MA). The corresponding secondary antibodies to these primary antibodies were used. Then, they were visualized with 3,3 0 -diaminobenzidine tetrahydrochloride. Five fields were randomly selected per section and positive nuclei for immunostaining for each antibody in ×20 field were counted by Y.T. and S.M. It was presented as proportion to the number of nuclei of all cells. The results were expressed as a mean with SD.
Statistical analysis
Continuous data of clinicopathological factors are presented as a median with quartile deviation (QD). Independent categorical data were compared by chi-square test and continuous data were compared by MannWhitney U-test. Correlation between actual post-operative FEV 1 (FEV 1apo )/FEV 1ppo and actual post-operative FVC (FVC apo )/FVC ppo was tested using linear regression analyses. To determine independent predictors, multivariate logistic regression model was performed. We preferentially selected clinical variables that were reported to be predictors of pulmonary function and stepwise regression was used to select the final variables for adjustment. Correlation was assessed using Spearman's rank correlation test. All tests were two-sided and P < 0.05 was considered to be significant. Statistical analysis was performed using SPSS (version 22; SPSS Inc., Chicago, IL, USA).
RESULTS
Patients
A total of 137 consecutive patients after major lung resection with complete follow-up data were included in this study. As shown in Table 1 
Long-term pulmonary function and its relationship with clinicopathological factors
First, FEV 1apo /FEV 1ppo was significantly correlated with FVC apo /FVC ppo (y = 0.40 + 0.63x, r = 0.628, P < 0.001; Fig. 1A ). In accordance with the definition of CR suggested by Ueda et al. 8 , we defined index of CR as FEV 1apo /FEV 1ppo and FVC apo /FVC ppo and then set the cut-off value of 120% for both FEV 1apo /FEV 1ppo and FVC apo /FVC ppo in the following analysis. As shown in Table 2 , greater CR was significantly associated with lesser smoking index (P < 0.001) and greater resected subsegments (P = 0.037).
Next, multivariate analysis was performed using the three variables including number of resected segments 4,9 and preoperative FEV 1 % 8,15 which were previously reported to be predictors of post-operative PFT, as well as smoking status which was shown to be significant above. Greater CR was independently correlated with the never-smoker group (OR: 1.988, 95% CI: 1.164-4.926, P = 0.014; Table 3 ).
In addition, we examined correlation between patient characteristics and degree of CR within the never-smoker group and the smoker group separately. There were no factors correlated to the degree of CR in either groups (Table S1 , Supplementary Information). Patient number in each subgroup may be insufficient to show significance.
Case-control-matched analysis
In the case-control-matched analysis, we used variables which were reported to be associated with PFT including advanced age, 16 male gender 17 and BMI 18 to minimize the effects of possible confounders on CR when comparing the smoker and never-smoker groups. It was confirmed that there was no significant difference of these variables between the two groups after matching (Table S2 , Supplementary Information). As shown in Figure 1B , FEV 1apo /FEV 1ppo of the neversmoker group is significantly higher than that of the smoker group (mean AE SD = 119.9 AE 12.5% vs 107.5 AE 14.2%, P = 0.030). FVC apo /FVC ppo of the neversmoker group and the smoker group were 117.9 AE 9.98% and 107.2 AE 13.1%, respectively, which revealed statistically significant difference (P = 0.046; Fig. 1C) .
Immunohistochemistry
In addition, we performed immunohistochemistry for pro-SPC, TTF-1 and VEGFR2 using the tissue section of normal lung parenchyma to clarify association of these molecular factors with CR ( Fig. 2A) . Figure 2B illustrates that immunohistochemistry for pro-SPC was found in the cytoplasm of alveolar type 2 epithelial cells (AEC2s), and percentage of positive cells of greater CR group and lesser CR group were 20.8 AE 1.05% and 13.4 AE 1.09%, respectively (mean AE SD, P < 0.001). TTF-1-positive nuclei was identified in AEC2s and the percentage of positive cells of greater CR group was significantly higher than that of the lesser CR group (9.25 AE 1.08% vs 5.47 AE 0.65%, P < 0.001; Fig. 2C ). Positive immunostaining for VEGFR2 of the greater CR group was significantly higher compared with that of the lesser CR group (6.69 AE 1.26% vs 4.52 AE 1.95%, P < 0.001; Fig. 2D ). As shown in Figure 3A , the proportion of expression of the three markers was strongly correlated to each other among all patients (pro-SPC vs TTF-1: r = 0.889, P < 0.001; pro-SPC vs VEGFR2: r = 0.604, P < 0.001; TTF-1 vs VEGFR2: r = 0.563, P < 0.001).
Significant correlation of the three markers was also shown within the smoker group (Fig. S1A , Supplementary Information; pro-SPC vs TTF-1: r = 0.887, P < 0.001; pro-SPC vs VEGFR2: r = 0.602, P < 0.001; TTF-1 vs VEGFR2: r = 0.548, P < 0.001), but not within the never-smoker group (Fig. S1B , Supplementary Information; pro-SPC vs TTF-1: r = 0.120, P = 0.087; pro-SPC vs VEGFR2: r = 0.114, P = 0.104; TTF-1 vs VEGFR2: r = 0.078, P = 0.267). The data suggest that the main finding of immunohistochemistry is decreased expression of the three markers which were all strongly correlated to each other in the smoker group. There was a significant correlation between TTF-1 and VEGFR2 expression, although no significant correlation was shown both between pro-SPC and TTF-1 and between pro-SPC and VEGFR2 within the greater CR group (Fig. S1C , Supplementary Information; pro-SPC vs TTF-1: r = 0.171, P = 0.457; pro-SPC vs VEGFR2: r = 0.075, P = 0.746; TTF-1 vs VEGFR2: r = 0.469, P = 0.032). However, the expression of three markers was not significantly correlated to each other within the lesser CR group (Fig. S1D , Supplementary Information; pro-SPC vs TTF-1: r = 0.346, P = 0.147; pro-SPC vs VEGFR2: r = 0.260, P = 0.283; TTF-1 vs VEGFR2: r = 0.086, P = 0.726).
To investigate the direct correlation between CR and the proportion of positive cells for the three markers, mean CR ratio was defined as mean of FEV 1apo / FEV 1ppo and FVC apo /FVC ppo . As shown in Figure 3B , there was an intermediate correlation between pro-SPC and mean CR ratio (r = 0.465, P < 0.001 in all patients; r = 0.631, P < 0.001 in the smoker group; r = 0.573, P < 0.001 in the never-smoker group). The expression of TTF-1 was also correlated to the mean CR ratio (r = 0.563, P < 0.001 in all patients; r = 0.705, P < 0.001 in the smoker group; r = 677, P < 0.001 in the never-smoker group; Fig. 3C ). Moreover, the expression of VEGFR2 showed strong correlation to the mean CR ratio (r = 0.601, P < 0.001 in all patients; r = 0.732, P < 0.001 in the smoker group; r = 0.545, P < 0.001 in the never-smoker group; Fig. 3D ). This suggested that the expression of pro-SPC, TTF-1 and VEGFR2 in the smoker group was more strongly correlated to the degree of CR compared with the neversmoker group.
DISCUSSION
This study indicated that the never-smoker group showed significantly greater CR after major lung resection in both the original and case-matched cohorts. In addition, the expressions of pro-SPC, TTF-1 and VEGFR2 in the normal lung of the greater CR group were significantly higher compared with those of the lesser CR group. Prediction of post-operative pulmonary function is an old but unsolved issue. We focused on the long-term pulmonary function because it can greatly affect QOL and pulmonary complications of 
Long-term lung function after lobectomy
long-term survivors after lung cancer resection. We investigated the PFT at 10-14 months after major lung resection because it was reported that PFT parameters reached plateau at approximately 9 months after major lung resection. 19 In our study, FEV 1apo /FEV 1ppo showed significantly linear correlation with FVC apo /FVC ppo , suggesting that functional recovery of FEV 1 would be almost directly proportional to that of FVC, which was in agreement with previous reports. 4, 8, 9 Based on this result, we defined index of CR as both FEV 1apo /FEV 1ppo and FVC apo /FVC ppo to distinguish from non-functional over-inflation due to the excessive shear stress after major lung resection as previously described. 4 We then identified the better cut-off value of 120% for both FEV 1apo /FEV 1ppo and FVC apo /FVC ppo , although this might be arbitrary.
Recently, several researchers focused on the importance of long-term pulmonary function after lung resection, 4, 8, 9 suggesting that it could consist of CR resembling partly compensatory lung growth in mice. The case-matched comparison in our study showed that the CR in the never-smoker group was significantly greater than that in the smoker group. Overall, our data also support that CR itself could rise after major lung resection. To the best of our knowledge, this is the first report demonstrating long-term pulmonary function by comprehensive analysis and then identifying smoking status as an independent predictor of CR. CR can contribute to improve QOL of long-term survivor after major lung resection as described above. Thus, QOL evaluation using scoring systems may be informative to highlight the clinical significance of CR. However, we did not examine diffusing capacity of the lung carbon monoxide (DL CO ), an important parameter of parenchymal function, because of the following reasons: (i) CT scan evaluation is sufficient to detect lung parenchymal disorder and (ii) evaluation of mechanical function such as FEV 1 and FVC is enough to investigate CR because it is extremely rare that patients without pre-existing parenchymal lung disorders to develop this in their post-operative course. Other parameters such as VO 2max can also provide us useful information to link actual pulmonary function with CR. These parameters should be investigated in further studies.
The expression of pro-SPC, TTF-1 and VEGFR2 in the normal lung parenchyma of greater CR group was significantly higher compared with those of the lesser CR group. Messier et al. reported that cigarette smoking caused oxidative stress resulting in impairment of AEC2s with chronic DNA damage. 20 Also, innate function of AEC2s was considered critical for maintenance and regeneration of alveolar epithelial cells via proliferation and differentiation to alveolar type 1 epithelial cells (AEC1s). 21 In addition, several reports demonstrated that the function of AEC2s presented as the expression of pro-SPC and TTF-1 in AEC2s plays a crucial role in compensatory lung growth which was morphologically characterized by rapid growth of septum of alveolar duct in mice. 11, 12, 22 Therefore, the current results suggest that the function of AEC2s may be essential for CR in patients who underwent major lung resection as well as for compensatory lung growth. Cigarette smoking has been generally recognized to be a main cause of pulmonary emphysema. 21, 23, 24 Also, decreased expression of vascular endothelial growth factor (VEGF) and VEGFR2 was associated with severe pulmonary emphysema. 25 It was expected that COPD including pulmonary emphysema could greatly affect PFT as well as degree of CR, although COPD did not significantly correlate to degree of CR in this study. However, COPD could affect the degree of CR based on the background data as well as the fact that we found larger number of COPD patients in the lesser CR group, even though we did not find significant differences in this study. This suggests that the capacity for CR could be affected by early molecular changes preceding morphological and functional changes in COPD.
In addition, reduced VEGF signalling reportedly contributes to destruction of alveolar wall and septum including vessels via impairment of maintenance of AEC2s in the pathogenesis of pulmonary emphysema. 26 Moreover, VEGFR2 as well as chemokine-related proteins are essential to induce compensatory lung growth after lobectomy in mice. 10, 27 Overall, our findings suggest that these proteins, which reportedly play crucial roles in regeneration and maintenance of the AEC2s, would be important for CR. Considering the possible mechanisms of CR, the expression of pro-SPC, TTF-1 and VEGFR2 in the normal lung parenchyma at the time of surgery may reflect physiological capacity for CR. This was supported by positive correlation between these markers and the degree of CR especially in the smoker group. Interestingly, there was a stronger correlation of the expression of these markers within the smoker group compared with the never-smoker group. Thus, these data suggested that decreased expression , thyroid transcription factor-1 (TTF-1) and vascular endothelial growth factor receptor 2 (VEGFR2) shown in ×10 field. Pro-SPC and TTF-1 were found in the cytoplasm of alveolar type 2 cells. VEGFR2 was expressed in the alveolar septum including endothelium (inset). (B) Immunohistochemistry for pro-SPC of the never-smoker group is higher than that of the smoker group (20.7 AE 1.02% vs 13.2 AE 1.16%, P < 0.001). (C) Proportion of TTF-1-positive cells of the never-smoker group is significantly higher than that of the smoker group (9.27 AE 1.04% vs 5.42 AE 0.69%, P < 0.001). (D) The expression of VEGFR2 of never-smoker group was significantly increased compared with that of the smoker group (6.79 AE 1.92% vs 4.34 AE 1.80%, P < 0.001).
Respirology ( Long-term lung function after lobectomy of these markers could contribute to lesser CR after major lung resection in probably the same mechanism as in the smoker population. However, we did not investigate co-localization of the markers that would be important to clarify whether the decreased expression of AEC2s-specific markers is attributed to the loss of AEC2s or molecular changes in AEC2s. Also, further examination of alveologenesis-promoting genes, chemokines and chemokine receptors that have been reported as crucial factors to promote compensatory lung growth may be useful to clarify mechanism of CR. 10, 27 Moreover, small airway disorders especially functional changes of basal cells could contribute to CR, 28 even though no histopathological changes were detected in this study. Overall, the current data suggest some similarities between CR after major lung resection in adult human and compensatory lung growth in rodents, even though further investigations are necessary.
Our findings also imply that long-term PFT of smokers is likely to be overestimated. In addition, smoking status is one of the predictor for post-operative complication as well as survival outcome. 29 Based on this, we should carefully consider the operability of heavy smokers in terms of both long-term lung function and oncological staging. This study has several limitations including information bias. The number of patients is relatively small. In addition, cut-off values of FEV 1apo /FEV 1ppo and FVC apo /FVC ppo could be arbitrary, although this is a pilot study. Moreover, our findings could not exactly reflect entire respiratory function because we did not examine other parameters such as DL CO and oxygen saturation in the peripheral blood. Further investigation with a larger patient cohort is needed.
In this study, we showed that patients who never smoked had significantly greater CR after major lung resection. In addition, the never-smoker group demonstrated significantly higher expression for pro-SPC, TTF-1 and VEGFR2. Our data suggest that CR preferably occurs in patients who retain the function of AEC2s. Correlation of the expression of the three markers among all patients (pro-surfactant protein C (pro-SPC) vs thyroid transcription factor-1 (TTF-1): r = 0.889, P < 0.001; pro-SPC vs vascular endothelial growth factor receptor 2 (VEGFR2): r = 0.604, P < 0.001; TTF-1 vs VEGFR2: r = 0.563, P < 0.001). Correlation was assessed using Spearman's rank correlation test. (B) Correlation between the mean compensatory response (CR) ratio and pro-SPC (r = 0.465, P < 0.001 in all patients; r = 0.631, P < 0.001 in the smoker group; r = 0.573, P < 0.001 in the never-smoker group). (C) Correlation between the mean CR ratio and TTF-1 (r = 0.563, P < 0.001 in all patients; r = 0.705, P < 0.001 in the smoker group; r = 677, P < 0.001 in the never-smoker group). (D) Correlation between the mean CR ratio and VEGFR2 showed similar correlation to the mean CR ratio (r = 0.601, P < 0.001 in all patients; r = 0.732, P < 0.001 in the smoker group; r = 0.545, P < 0.001 in the never-smoker group). Correlation was assessed using Spearman's rank correlation test. , Never-smoker; , smoker. editing this manuscript. This study was partly supported by JSPS KAKENHI Grant Number 26462137.
